Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.

 

2021 Virtual Best of Breast
16:02

2021 Virtual Best of Breast

Case Study of Premenopausal Woman With HR+, HER2- MBC: What Does the PFS Data Show With Ribociclib After Progression on CDK4/6i? How Can Alpelisib Toxicities Be Managed?

FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
  • 276 views
  • February 22, 2021
08:26

2021 Virtual Best of Breast

HR+/HER2- MBC: What Are the Biopsy and 1L Treatment Options Using NCCN Guidelines? How Do We Apply CDK4/6i Trials Data to Clinical Practice?

FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
  • 396 views
  • January 25, 2021
  • 1
14:15

2021 Virtual Best of Breast

Breast Cancer Genetic Testing: What Are the Most Common Mutations? What Is the Difference Between Genetic & Genomic Testing?

FEATURING Wendy K. Chung, Jennifer Klemp, Jane Meisel, Monica Yepes
  • 33 views
  • February 5, 2021
15:59

2021 Virtual Best of Breast

Optimizing Genetic Testing for BC: Who & When Should Get Tested?

FEATURING Wendy K. Chung, Jennifer Klemp, Jane Meisel, Monica Yepes
  • 18 views
  • February 5, 2021
17:37

2021 Virtual Best of Breast

PARPi for BC With Germline Mutations: Why Are They Good Option for BRCA-Mutated Disease? Should We Consider for Other Mutations?

FEATURING Wendy K. Chung, Jennifer Klemp, Jane Meisel, Monica Yepes
  • 125 views
  • February 5, 2021
08:46

2021 Virtual Best of Breast

BC Risk Management: Should We Be Offering Testing to Everyone? Do We Have the Capacity to Do This?

FEATURING Wendy K. Chung, Jennifer Klemp, Jane Meisel, Monica Yepes
  • 91 views
  • February 5, 2021
13:34

2021 Virtual Best of Breast

BC Cascade Testing: How Can Patients Use Testing to Inform Their Families of Cancer Risks?

FEATURING Wendy K. Chung, Jennifer Klemp, Jane Meisel, Monica Yepes
  • 92 views
  • February 5, 2021
  • 1
06:14

2021 Virtual Best of Breast

Combatting Endocrine Resistance in BC: Use of Integrated Medicine Approaches, Epigenetics

FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
  • 44 views
  • January 25, 2021
19:31

2021 Virtual Best of Breast

Endocrine Decision Making in BC: OFS+Tamoxifen/Exemestane - What Produces Better DFS? How to Manage Symptoms of AI Therapy? Does Adjuvant Abemaciclib+Standard ET Improve IDFS?

FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
  • 48 views
  • January 25, 2021
06:18

2021 Virtual Best of Breast

40 y/o Premenopausal Woman With mBC: Does LRT for the IPT Show Survival Benefit Following Initial Systemic Therapy?

FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
  • 25 views
  • January 25, 2021
09:19

2021 Virtual Best of Breast

BC Side Effects: What Are the Key Points That Need to Be Assessed at Regular Intervals? What Are the NCCN Survivorship Guidelines?

FEATURING Jennifer Klemp, Kristina Mirabeau-Beale, Kristin Rojas, Mayra Lima
  • 26 views
  • January 21, 2021
07:34

2021 Virtual Best of Breast

Postmenopausal Woman With Triple-Positive Breast Cancer: How to Approach a Patient With Serious Side Effects?

FEATURING Jennifer Klemp, Kristina Mirabeau-Beale, Kristin Rojas, Mayra Lima
  • 118 views
  • January 21, 2021
22:46

2021 Virtual Best of Breast

56 y/o Postmenopausal Woman With Triple-Positive BC: Estrogen Deprivation, Menopausal Symptoms/Sexual Health Concerns, Hot Flashes & Mood Changes, GSM & Painful Sex

FEATURING Jennifer Klemp, Kristina Mirabeau-Beale, Kristin Rojas, Mayra Lima
  • 128 views
  • January 21, 2021
  • 1
10:46

2021 Virtual Best of Breast

BC Side Effects & Survivorship: What Are the Most Common AI-Related Complaints?

FEATURING Jennifer Klemp, Kristina Mirabeau-Beale, Kristin Rojas, Mayra Lima
  • 86 views
  • January 21, 2021
13:24

2021 Virtual Best of Breast

BC & Menopause Side Effects: Cardio-Toxicity, Cardiac Sparing Radiation, Skin Changes - How to Prevent Them, Risk & Prevention of Lymphedema

FEATURING Jennifer Klemp, Kristina Mirabeau-Beale, Kristin Rojas, Mayra Lima
  • 21 views
  • January 21, 2021
06:12

2021 Virtual Best of Breast

BC Side Effects: Cost of Cancer Care - Determinants, Effects & Barriers for Financial Toxicity

FEATURING Jennifer Klemp, Kristina Mirabeau-Beale, Kristin Rojas, Mayra Lima
  • 17 views
  • January 21, 2021
12:07

2021 Virtual Best of Breast

40 y/o Premenopausal Woman With Palpable Right Breast Mass: Should We Use Preoperative Systemic Therapy? Does Tumor Biology Correlate With Rates of Breast-Conserving Surgery and pCR After Neoadjuvant Chemo?

FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
  • 24 views
  • January 21, 2021
21:39

2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Is IDFS Better With ET Alone or After Chemo? Does TaxAC Regimen Improve Survival in HER2- Disease? Can We Use Anthracycline-Free Chemo? Are There Scalp Cooling Benefits?

FEATURING Laura Freedman, Kevin Kalinsky, Terry Mamounas, Lauren Nye
  • 126 views
  • January 21, 2021
21:08

2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Does PMRT After ALND Reduce the Risk of LRF? Should We Use It After SNB? What Is the Risk of Reconstructive Failure?

FEATURING Laura Freedman, Kevin Kalinsky, Terry Mamounas, Lauren Nye
  • 45 views
  • January 21, 2021
09:37

2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Does OFS+Exemestane Improve DRFI? What Are the Survivorship Considerations? How to Preserve Fertility?

FEATURING Laura Freedman, Kevin Kalinsky, Terry Mamounas, Lauren Nye
  • 240 views
  • January 21, 2021
  • 1
14:59

2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Can Tamoxifen Reduce Mortality in ER+ Patients? What Is the Optimal Duration of ET (Letrozole)?

FEATURING Laura Freedman, Kevin Kalinsky, Terry Mamounas, Lauren Nye
  • 701 views
  • January 21, 2021
  • 7
21:20

2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Genetic Counseling/Testing, Bilateral Breast MRI, Gene Assessment & Algorithm for HER2 Testing (IHC & FISH)

FEATURING Amanda Amin, Elisa Krill-Jackson, Kevin Kalinsky, Michael Press
  • 79 views
  • January 21, 2021
14:28

2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Can We Achieve pCR With Pembro/Atezo? What Patients Should Be Utilizing Carboplatin?

FEATURING Amanda Amin, Elisa Krill-Jackson, Kevin Kalinsky, Michael Press
  • 51 views
  • January 21, 2021
07:08

2021 Virtual Best of Breast

55 y/o Woman With mTNBC: What Is the FNR of SLN Surgery After Chemo? How Important Is the Assessment of the Axilla?

FEATURING Amanda Amin, Elisa Krill-Jackson, Kevin Kalinsky, Michael Press
  • 17 views
  • January 21, 2021
03:22

2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Does Adjuvant Capecitabine Improve DFS After Preoperative Chemo? What About Pembro and iDFS?

FEATURING Amanda Amin, Elisa Krill-Jackson, Kevin Kalinsky, Michael Press
  • 22 views
  • January 21, 2021
10:19

2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Is Atezo+Nab-Paclitaxel Beneficial for PFS/OS in PD-L1 Disease? What About Pembro+Chemo in Previously Untreated Patients?

FEATURING Amanda Amin, Elisa Krill-Jackson, Kevin Kalinsky, Michael Press
  • 335 views
  • January 21, 2021
09:43

2021 Virtual Best of Breast

2021 Update on New Agents for mTNBC: ADCs (Sacituzumab Govitecan, Ladiratuzumab Vedotin), PARPi (Olaparib, Talazoparib), AKTi (Capivasertib/Ipatasertib+Paclitaxel)

FEATURING Amanda Amin, Elisa Krill-Jackson, Kevin Kalinsky, Michael Press
  • 320 views
  • January 21, 2021
  • 1
09:00

2021 Virtual Best of Breast

59 y/o Woman With HER2+ Invasive Ductal Carcinoma: Is Neoadjuvant Trastuzumab/Pertuzumab the Best Choice? How to Manage Pertuzumab-Induced Diarrhea?

FEATURING Penny Anderson, Sunil Badve, Erika Hamilton, Reshma L. Mahtani
  • 204 views
  • January 21, 2021
  • 2
12:44

2021 Virtual Best of Breast

59 y/o Woman With HER2+ EBC: Should We Choose T-DM1 as Post-Neoadjuvant Systemic Treatment? Can We Follow With Mastectomy? What Is DIBH?

FEATURING Penny Anderson, Sunil Badve, Erika Hamilton, Reshma L. Mahtani
  • 18 views
  • January 21, 2021
11:19

2021 Virtual Best of Breast

HER2+ mBC Case Study Discussion: PFS Data of Tucatinib + Trastuzumab + Capecitabine in Patients With Brain Mets

FEATURING Penny Anderson, Sunil Badve, Erika Hamilton, Reshma L. Mahtani
  • 399 views
  • January 21, 2021
22:37

2021 Virtual Best of Breast

Case Study Discussion on HER2+ MBC: Trastuzumab Deruxtecan in Heavily Pretreated Patient, Management of Interstitial Lung Disease

FEATURING Penny Anderson, Sunil Badve, Erika Hamilton, Reshma L. Mahtani
  • 254 views
  • January 21, 2021
  • 1